A Study to Test How Different Doses of BI 3814916 Are Tolerated by Healthy People

Recruiting now · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3814916 in healthy male and female trial participants.

Key facts

Study ID
NCT07486115
Run by
Boehringer Ingelheim
People needed
136
Starts
2026-05-20
Expected to finish
2027-07-12
Last updated by the study team
2026-05-28

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.